Prohost Biotech - Exclusive Biotech Research - A Comprehensive Resource for Biotech News

Altimmune Important Upcoming Presentations

June 18, 2024 0

Altimmune Today, June 18, 2024, Altimmune (ALT) announced oral presentations on pemvidutide, an investigational GLP-1/glucagon dual …

RegenxBio Announced Completion of a Successful Pre-BLA Meeting with the FDA for RGX-121 for Mucopolysaccharidosis Type II

June 18, 2024 0

RegenxBio Today RegenxBio (RGNX) announced it completed a successful Pre-Biologics License Application (BLA) meeting with the …

AstraZeneca: The U.S. FDA Approved IMFINZI in Combination with Carboplatin and Paclitaxel followed by IMFINZI Monotherapy for Adults with Primary Advanced or Recurrent Endometrial Cancer

June 17, 2024 0

US FDA Approval for AstraZeneca’s IMFINZI AstraZeneca (AZN): The trial results of the FDA newly approved …

Broadcom Inc. Announces 2Q Fiscal Year 2024 Financial Results, Quarterly Dividend and Stock Split 10-1

June 14, 2024 0

Broadcom Inc Announcements What analysts heard from the Artificial Intelligence (AI) firm Broadcom Inc is promising …

ASCO 2024: Innovent Biologics Delivers Oral Presentation of Clinical Data of a Randomized Controlled Phase 1b Study Evaluating IBI310 in Combination with Sintilimab as Neoadjuvant Treatment of Colon Cancer

June 13, 2024 0

Innovent Biologics Announcement at ASCO Innovent Biologics , Inc. (HKEX: 01801)(OTC: IVBXF) announced that the clinical . …

Eli Lilly Product Tirzepatide Has Impressive Clinical Trial Results Treating MASH

June 10, 2024 0

Eli Lilly in the NEWS Eli Lilly and Company (LLY) announced detailed results from the SYNERGY-NASH …

Gilead Sciences and Arcus Biosciences: Treating Gastrointestinal Cancers

June 6, 2024 0

Gilead Sciences and Arcus Biosciences in the NEWS Gilead Sciences (GILD) and Arcus Biosciences (RCUS) announced …

What About Agenus?

June 5, 2024 0

Answering Questions and Our Opinion About Agenus We believe that Agenus' (AGEN) frozen stock price for several …

Ionis Pharmaceuticals Presented Positive Results from Two Late Studies of investigational Product Donidalorsen

June 3, 2024 0

Ionis Parmaceuticals Treating Hereditary Angioedema On May 31, 2024, Ionis Pharmaceuticals (IONS) announced positive results from …

Prohost Letter #460 ~ Treating IgA Nephropathy

June 1, 2024 0

Prohost Letter #460 Treating IgA Nephropathy Immunoglobulin A (IgA), the antibody of the immune system known …

Autonomix Medical Preclinical Study Successfully Demonstrates That Nerve Ablation Can Slow Tumor Metastasis in Pancreatic Cancer

May 23, 2024 0

Autonomix Medical Announcement May 23, 2024, Autonomix Medical (AMIX) announced successful completion of an animal study …

Moderna Announces Data to be Presented at 2024 ASCO Annual Meeting

May 23, 2024 0

Moderna to Host Investor Event Via Webcast Moderna, Inc. (MRNA) announced that three abstracts on mRNA-4157 …

Pivotal Data About Efficacy and Tolerability of Arcturus Therapeutics’ COVID-19 Vaccine Published in Nature Communications

May 22, 2024 0

Arcturus Therapeutics COVID-19 Vaccine Published CSL (ASX:CSL; USOTC:CSLLY) and Arcturus Therapeutics (ARCT) announced that Journal Nature …

Verrica Pharmaceuticals: Collaboration and License Agreements for the Treatment of Skin Diseases Other Than Molluscum Contagiosum

May 16, 2024 0

Verrica Pharmaceuticals Verrica Pharmaceuticals’ (VRCA) product YCANTH (cantharidin) is the only commercially available treatment approved by …

Jennifer Schneider Elected to Vertex Pharmaceuticals Board of Directors. Why It’s Good News

May 15, 2024 0

Vertex Pharmaceuticals News Today, May 15, 2024, Vertex Pharmaceuticals (VRTX) announced that Jennifer Schneider, M.D., M.S., …

Regeneron: Improved Hearing to Normal Levels in a Child with Profound Genetic Deafness

May 8, 2024 0

Regeneron in the NEWS Regeneron Pharmaceuticals (REGN) announced today that the investigational gene therapy DB-OTO improved …

CRISPR Therapeutics Highlights ASGCT Oral Presentation and Announces New Programs Utilizing In Vivo Gene Editing Approach

May 8, 2024 0

Crispr Therapeutics in the NEWS CRISPR Therapeutics (CRSP) announced new preclinical data presented at the 27th …

Vertex Pharmaceuticals Reports First Quarter 2024 Financial Results

May 7, 2024 0

Vertex Pharmaceuticals Vertex Pharmaceuticals (VRTX) reported consolidated financial 2024 results for the first quarter ended March …

CytomX is Rallying Today! The Firm Will Report Q1 2024 Results and Provide an Initial CX-904 Phase 1a Clinical Data Update on May 8, 2024

May 1, 2024 0

CytomX Therapeutics CytomX Therapeutics, Inc. (CTMX) announced that it will report first quarter 2024 results and …

TG Therapeutics Stock Price is Rising as Q1 Revenues from BRIUMVI U.S. Have Exceeded Expectations

May 1, 2024 0

TG Therapeutics Financial Results for Q1 2024 TG Therapeutics, Inc. (TGTX) announced its financial results for …

Exclusive Market Insight

& Scientific analysis

Latest Articlesddd

Altimmune Important Upcoming Presentations

RegenxBio Announced Completion of a Successful Pre-BLA Meeting with the FDA for RGX-121 for Mucopolysaccharidosis Type II

AstraZeneca: The U.S. FDA Approved IMFINZI in Combination with Carboplatin and Paclitaxel followed by IMFINZI Monotherapy for Adults with Primary Advanced or Recurrent Endometrial Cancer

Broadcom Inc. Announces 2Q Fiscal Year 2024 Financial Results, Quarterly Dividend and Stock Split 10-1

ASCO 2024: Innovent Biologics Delivers Oral Presentation of Clinical Data of a Randomized Controlled Phase 1b Study Evaluating IBI310 in Combination with Sintilimab as Neoadjuvant Treatment of Colon Cancer

Eli Lilly Product Tirzepatide Has Impressive Clinical Trial Results Treating MASH

Gilead Sciences and Arcus Biosciences: Treating Gastrointestinal Cancers

What About Agenus?

Ionis Pharmaceuticals Presented Positive Results from Two Late Studies of investigational Product Donidalorsen

Prohost Letter #460 ~ Treating IgA Nephropathy

Autonomix Medical Preclinical Study Successfully Demonstrates That Nerve Ablation Can Slow Tumor Metastasis in Pancreatic Cancer

Moderna Announces Data to be Presented at 2024 ASCO Annual Meeting

Pivotal Data About Efficacy and Tolerability of Arcturus Therapeutics’ COVID-19 Vaccine Published in Nature Communications

Verrica Pharmaceuticals: Collaboration and License Agreements for the Treatment of Skin Diseases Other Than Molluscum Contagiosum

Jennifer Schneider Elected to Vertex Pharmaceuticals Board of Directors. Why It’s Good News

Regeneron: Improved Hearing to Normal Levels in a Child with Profound Genetic Deafness

CRISPR Therapeutics Highlights ASGCT Oral Presentation and Announces New Programs Utilizing In Vivo Gene Editing Approach

Vertex Pharmaceuticals Reports First Quarter 2024 Financial Results

CytomX is Rallying Today! The Firm Will Report Q1 2024 Results and Provide an Initial CX-904 Phase 1a Clinical Data Update on May 8, 2024

TG Therapeutics Stock Price is Rising as Q1 Revenues from BRIUMVI U.S. Have Exceeded Expectations